Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor Statesort icon
16/02/2017 Phase I with CIGB-814 in rheumatoid arthritis patients CIGB Registered
06/08/2014 Heptavalent Conjugate Vaccine against Pneumococcal (VCN7-T) in healthy children. CQB Registered
23/04/2014 CIGB-500 in acute myocardial infarction (AMIGOS study) CIGB Registered
27/06/2014 D-002 and glucosamine/chondroitin sulphate in osteoarthritis CPN Registered
11/09/2014 NeuroEPO-Stroke. Phase I-II CIMAB Registered
02/11/2014 NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II CIMAB Registered
22/05/2015 Itolizumab for Relapsing Remitting Multiple Sclerosis CIM Registered
29/01/2016 Predictor of response with CIMAvax EGF© in NSCLC Phase III CIM Registered
17/02/2017 Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II BIOCEN Registered
06/11/2014 Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . FINLAY Registered
10/11/2014 CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. CIGB Registered
08/10/2015 Itolizumab for Moderate-to-Severe Psoriasis-phase 3 CIM Registered
23/12/2016 Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus CIM Registered
08/04/2015 Combifer vs Trofin phase II in anemic pregnant women. BIOCEN Registered
12/05/2015 Vitamin E/ Platinum salts CIDEM Registered
13/04/2015 Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II BIOCEN Registered
13/04/2015 Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. BIOCEN Registered
08/04/2015 THERESA-5 Study CIGB Registered
22/05/2015 Safety and pharmacokinetics of CIGB-552 CIGB Registered
04/10/2023 Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana FINLAY Registered